Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma

被引：0
作者：
Laurence Legros
Alina Pascale
Catherine Guettier
Pirayeh Eftekhari
Yasmina Ben Merabet
Maryse Stang
Rachel Bossevot
Emma Goldschmidt
Ayhan Ulusakarya
Stephane Morisset
Maïté Lewin
Didier Samuel
Olivier Rosmorduc
机构：
[1] Hôpital Bicêtre,Department of Clinical Hematology
[2] AP-HP,Hepato
[3] INSERM UMRS-MD-1197,Biliary Department
[4] Université Paris-Saclay,Anatomic Pathology Department
[5] France Intergroupe Syndromes Myéloprolifératifs (FIM),Medical Oncology Department
[6] Hôpital Paul Brousse,Radiology Department
[7] AP-HP,undefined
[8] Hôpital Bicêtre,undefined
[9] AP-HP,undefined
[10] Hôpital Paul Brousse,undefined
[11] AP-HP,undefined
[12] Independent Biostatistician,undefined
[13] Hôpital Paul Brousse,undefined
[14] AP-HP,undefined
[15] INSERM U1193,undefined
[16] Université Paris-Saclay,undefined
[17] Sorbonne Université,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2023年 / 91卷
关键词：
Hepatocellular carcinoma; Lenvatinib; Antiangiogenic drugs; Erythrocytosis; Erythropoietin; Thromboprophylaxis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 344
页数：7
相关论文
共 135 条
[11]  
Finn RS(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-140
[12]  
Qin S(1981)A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 30 239-473
[13]  
Finn RS(2008)The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database Fundam Clin Pharmacol 22 127-28
[14]  
Qin S(2009)Axitinib induces paradoxical erythropoietin synthesis in metastatic renal cell carcinoma J Clin Oncol 27 472-770
[15]  
Ikeda M(2019)Escalating erythrocytosis after start of pazopanib-treatment in metastatic renal cell carcinoma J Curr Oncol 2 26-395
[16]  
Bruix J(2021)Pazopanib-related secondary polycythemia in metastatic myxofibrosarcoma: a case report and review of the literature J Oncol Pharm Pract 27 766-E450
[17]  
Qin S(2015)Symptomatic secondary polycythemia induced by anti-VEGF therapy for the treatment of metastatic renal cell carcinoma: a case series and review Clin Genitourin Cancer 13 e391-6982
[18]  
Merle P(2017)Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma Can Urol Assoc J 11 E449-4048
[19]  
Abou-Alfa GK(2016)Sunitinib-induced erythrocytosis: case report and review of literature Int J Clin Exp Med 9 6980-478
[20]  
Meyer T(2008)Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib J Clin Oncol 26 4047-232
12345678910